Market Cap to Net Assets Ratio: zynex.com (ZYXI)

Zynex, Inc. (ZYXI) develops smart electrotherapy systems featuring automatic pulse adjustment and IT monitoring. The company is expanding the home pain management environment through NexWave, replacing medication with service-based rehabilitation. This price chart on GURU.Markets reflects a market trend for the asset currently at -0.09. High barriers to entry are maintained by patents, FDA approval, and insurance codes, which provide a robust moat against new competitors.

This metric reflects the gap between the market valuation of Zynex, Inc. (ZYXI) and the value of its net assets. A decline in the market value-to-book value ratio allows for an assessment of the rate at which the market premium is compressing. It is critically important to account for the debt load to avoid false signals of undervaluation. This chart reflects market expectations regarding intensive R&D developments. Breakthrough FDA releases concerning new fluid monitors could significantly revise this premium.